Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

746 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study.
Nontawong N, Siripongboonsitti T, Tawinprai K, Boonpratoom M, Krailassiri N, Boonkhum C, Soonklang K, Poovorawan Y, Mahanonda N. Nontawong N, et al. Among authors: poovorawan y. Ann Clin Microbiol Antimicrob. 2022 Nov 19;21(1):51. doi: 10.1186/s12941-022-00542-2. Ann Clin Microbiol Antimicrob. 2022. PMID: 36403020 Free PMC article.
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study.
Wanlapakorn N, Suntronwong N, Phowatthanasathian H, Yorsaeng R, Vichaiwattana P, Thongmee T, Auphimai C, Srimuan D, Thatsanatorn T, Assawakosri S, Kanokudom S, Poovorawan Y. Wanlapakorn N, et al. Among authors: poovorawan y. Hum Vaccin Immunother. 2022 Dec 31;18(1):2029111. doi: 10.1080/21645515.2022.2029111. Epub 2022 Feb 24. Hum Vaccin Immunother. 2022. PMID: 35209809 Free PMC article.
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
Chansaenroj J, Yorsaeng R, Puenpa J, Wanlapakorn N, Chirathaworn C, Sudhinaraset N, Sripramote M, Chalongviriyalert P, Jirajariyavej S, Kiatpanabhikul P, Saiyarin J, Soudon C, Thienfaidee O, Ayuthaya TPN, Brukesawan C, Intharasongkroh D, Chaiwanichsiri D, Issarasongkhram M, Kitphati R, Mungaomklang A, Thitithanyanont A, Nagavajara P, Poovorawan Y. Chansaenroj J, et al. Among authors: poovorawan y. PLoS One. 2022 Apr 21;17(4):e0267102. doi: 10.1371/journal.pone.0267102. eCollection 2022. PLoS One. 2022. PMID: 35446889 Free PMC article.
Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab).
Siripongboonsitti T, Nontawong N, Tawinprai K, Suptawiwat O, Soonklang K, Poovorawan Y, Mahanonda N. Siripongboonsitti T, et al. Among authors: poovorawan y. Microbiol Spectr. 2023 Dec 12;11(6):e0325723. doi: 10.1128/spectrum.03257-23. Epub 2023 Nov 17. Microbiol Spectr. 2023. PMID: 37975699 Free PMC article. Clinical Trial.
Seroprevalence of tetanus antibody in the Thai population: a national survey.
Chatchatee P, Chatproedprai S, Warinsathien P, Tharmaphornpilas P, Yoocharoen P, Warintrawat S, Theamboonlers A, Chongsrisawat V, Poovorawan Y. Chatchatee P, et al. Among authors: poovorawan y. Asian Pac J Allergy Immunol. 2007 Dec;25(4):219-23. Asian Pac J Allergy Immunol. 2007. PMID: 18402295 Free article.
746 results